Researchers revisit arteriovenous profiling - comparing changes in the metabolome of arterial versus venous blood in the diagnosis of disease - using targeted and untargeted LC–MS methods.
Researchers revisit arteriovenous profiling - comparing changes in the metabolome of arterial versus venous blood in the diagnosis of disease - using targeted and untargeted LC–MS methods.
Photo Credit: TEK IMAGE/Getty Images
Profiling blood samples for biomarker discovery is a well-established technique, but often requires hundreds (ideally thousands) of samples to identify new biomarkers of disease. A new study published in Scientific Reports outlines an approach comparing the metabolite ratios in arterial versus venous blood using hydrophilic interaction chromatography coupled to mass spectrometry (HILIC–MS).1 Changes in metabolite ratios could indicate alterations in metabolism and therefore be used as an aid to diagnose disease.
This is not a new approach according to authors Julijana Ivanisevic and Gary Siuzdak who told The Column that it was first applied in early fundamental physiology studies between the 1930s and 1970s. Since then however, the power of mass spectrometry and allied separation techniques has developed massively. Metabolic profiling of blood samples using MS-based techniques is now standard practice in many clinical laboratories to diagnose diseases including diabetes and cardiovascular disease. The application of metabolic profiling in biomarker discovery is, however, somewhat limited. Small changes in metabolite levels can be masked or lost due to high inter-individual variability depending on the numerous factors, such as age, diet, and health status. Studying the paired arteriovenous ratios, within the same individual, reduces the effect of this variation.
Ivanisevic said: “We wish to stimulate the researchers to go beyond the largeâscale systemic blood screening with the focus on biomarker discovery and apply the paired arteriovenous analysis at the organ level to better characterize organ specific activity and response to different physiological and pathological conditions. Looking for disease biomarkers using the traditional venous blood draw the dilution effect is very significant, which largely explains why the success rate for identifying and validating new biomarkers has been low.”
Samples of blood were taken from a group of 20 healthy adults to compare differences in arterial and venous blood from across human forearm tissue (radial artery and brachial vein) following an overnight fast. Untargeted HILIC–MS profiling detected more than 8000 metabolite features - glutamate levels decreased and lactate increased in venous blood samples compared to arterial blood samples. Targeted profiling was then performed to determine changes in the levels of 36 endogenous metabolites using multiple reaction monitoring. Paired statistical testing was performed on each individual, as opposed to random comparison of one set of samples to another. The authors emphasize that the paired analyses was key to the success of the approach - it was highly sensitive and capable of revealing small changes.
In terms of future work, Siuzdak and Ivanisevic told The Column: “We are pursuing this from multiple angles, as you can imagine any organ that has undergone a disease perturbation could yield very interesting results. More specifically, our intention is to apply the arteriovenous approach to study the organs that are hard to access such as the human brain, for example.” - B.D.
Reference
1. J. Ivanisevic et al., Scientific Reports DOI: 10.1038/srep12757 (2015).
Identifying Antioxidative Properties in Berries with UHPLC-MS
Published: November 27th 2024 | Updated: November 27th 2024A recent study identified and quantified anthocyanin (which are known for their antioxidative properties and potential effectiveness against depression) in blueberries, blackberries, black mulberries, and cranberries using ultra high-pressure liquid chromatography (UHPLC) followed by in vivo evaluation of their antidepressant-like activities.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Innovative cryogen-free ambient air monitoring of trace-level air toxics at high humidity
November 27th 2024This application note presents an advanced analytical system for the sensitive detection of trace-level air toxics in humid ambient air samples, in accordance with US EPA Method TO-15A. The cryogen-free preconcentration and thermal desorption approach, coupled to GC-MS, delivers exceptional chromatographic performance even for highly volatile and polar compounds. The system meets the stringent detection limit requirements of the latest air monitoring regulations, with method detection limits as low as 0.7 pptv. This innovative analytical solution provides a robust, cost-effective platform for the reliable quantification of hazardous air pollutants, enabling compliance with regulatory standards.
Continuous, cryogen-free on-line monitoring of PAMS in ambient air using hydrogen carrier gas
November 27th 2024This application note explores an efficient, helium-free method for continuous monitoring of ozone precursors in ambient air, aligned with EPA PAMS requirements. By using hydrogen as the carrier gas, this approach achieves faster run times, stable retention times, and effective separation of volatile organic compounds. A case study from New York City highlights the system's performance in urban air quality monitoring, capturing shifts in pollutant levels during periods of reduced traffic. With remote operability and cryogen-free functionality, this method offers a reliable and sustainable solution for real-time air quality analysis in both urban and remote environments.